Brief: Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell
26/06/2026 21:41
BRIEF-Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell June 26 (Reuters) - Neuphoria Therapeutics Inc NEUP.O:
NEUPHORIA THERAPEUTICS - IN TALKS WITH SCANCELL ABOUT POSSIBLE COMBINATION
NEUPHORIA THERAPEUTICS - CONFIRMS DISCUSSIONS ON POTENTIAL ACQUISITION BY SCANCELL, WHICH WOULD BECOME NASDAQ-LISTED
Source text: ID:nGNX5X6Vp4
Further company coverage: NEUP.O